Visa Drugs & Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Kolkata, West Bengal, India, established in 2008.
2008 Kolkata, West Bengal, India Dissolved Under Section 54
Last Updated:
About Visa Drugs & Pharmaceuticals Private Limited

Visa Drugs & Pharmaceuticals Private Limited, a dissolved under section 54 private limited company, was established on 07 July 2008 in Kolkata, West Bengal, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U85100WB2008PTC127222. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹4.00 Cr and a paid-up capital of ₹4.00 Cr.

Formerly known as Duphar Pharmaceuticals India Private Limited. It upholds a active non-compliant status. Employing 46 professional, Its leadership includes Ramdeo Ram (Director), Phool Chandra Yadav (Director). Past directors included Susmita Adhikary, Manoj Sardar, Madhusudan Balasaria. It holds no open charges and ₹359.90 Cr settled loans. Its latest AGM occurred on 30 September 2016, with the balance sheet filed on 31 March 2016. It is based at Room No. A-402/8, Bagree Market 71, Biplabi Rashbehari Basu, Kolkata, West Bengal, 700001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85100WB2008PTC127222

  • Registration Number

    127222

  • Incorporation Date

    07 July 2008

  • Authorized Capital

    ₹4.00 Cr

  • Paid-Up Capital

    ₹4.00 Cr

  • ROC Code

    Roc Kolkata

  • Listing Status

    Unlisted

  • Company Status

    Dissolved Under Section 54

Key Metrics
  • Authorised Capital ₹ 4.00 Cr
  • Paid Up Capital ₹ 4.00 Cr
  • Company Age 17 Year, 7 Months
  • Last Filing with ROC 31 Mar 2016
  • Satisfied Charges ₹ 359.90 Cr
  • Revenue Growth **** 31.98%
  • Profit Growth **** 54.40%
  • Ebitda **** 42.47%
  • Net Worth 17.96%
  • Total Assets **** 25.59%
Company report

Visa Drugs & Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Visa Drugs & Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Visa Drugs & Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Ramdeo Ram Director 01 Apr 2016 Current
Phool Chandra Yadav Director 27 Jan 2017 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Jan 2020 Past
Pramod Abcsdd Director 01 Jan 2020 Past
Pramod Abcsdd Director 02 Apr 2016 Past
Pramod Abcsdd Director 02 Apr 2016 Past
Pramod Abcsdd Director 30 Dec 2019 Past
Pramod Abcsdd Director 30 Dec 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Visa Drugs & Pharmaceuticals.

Visa Drugs & Pharmaceuticals Private Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 31.98% increase. The company also saw a substantial improvement in profitability, with a 54.4% increase in profit. The company's net worth Soared by an impressive increase of 17.96%.

Visa Drugs & Pharmaceuticals revenue growth over time
Visa Drugs & Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
31.98%
*******
*******
*******
*******
Revenue from Operations
*******
31.98%
*******
*******
*******
*******
Total Assets
*******
25.59%
*******
*******
*******
*******
Profit or Loss
*******
54.40%
*******
*******
*******
*******
Net Worth
*******
17.96%
*******
*******
*******
*******
EBITDA
*******
42.47%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Visa Drugs & Pharmaceuticals?

In 2016, Visa Drugs & Pharmaceuticals had a promoter holding of 43.45% and a public holding of 56.55%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹3,599,000,000.00

Charges Breakdown by Lending Institutions
  • Syndicate Bank : 200.65 Cr
  • Allahabad Bank : 90.00 Cr
  • State Bank Of India : 69.25 Cr
Latest Charge Details
Date Lender Amount Status
12 Aug 2016 Syndicate Bank ₹97.00 Cr Satisfied
27 Nov 2014 Syndicate Bank ₹103.65 Cr Satisfied
20 Aug 2011 State Bank Of India ₹69.25 Cr Satisfied
04 Jun 2010 Allahabad Bank ₹35.00 Cr Satisfied
10 Apr 2010 Allahabad Bank ₹27.50 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Visa Drugs & Pharmaceuticals?

Visa Drugs & Pharmaceuticals has a workforce of 46 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Visa Drugs & Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Visa Drugs & Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Visa Drugs & Pharmaceuticals
Recent Activity within the Organization
  • Charges

    Progress on A charge registered on 12 Aug 2016 via Charge ID 100076992 with Syndicate Bank was fully satisfied on 10 Jun 2022. was documented.

  • Charges

    A charge registered on 27 Nov 2014 via Charge ID 10540896 with Syndicate Bank was fully satisfied on 10 Jun 2022. was recorded as a recent event.

  • Director Appointment

    The activity Phool Chandra Yadav was appointed as a Director was appointed as a Director on 27 Jan 2017 & has been associated with this company since 9 years 1 month . was completed.

  • Annual General Meeting

    The activity Visa Drugs & Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2016 as per latest MCA records. was completed.

  • Charges

    A charge with Syndicate Bank amounted to Rs. 97.00 Cr with Charge ID 100076992 was registered on 12 Aug 2016. was recorded as a recent event.

  • Director Appointment

    The activity Ramdeo Ram was appointed as a Director was appointed as a Director on 01 Apr 2016 & has been associated with this company since 9 years 11 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Visa Drugs & Pharmaceuticals Private Limited?

The CIN of Visa Drugs & Pharmaceuticals Private Limited is U85100WB2008PTC127222.

Where is Visa Drugs & Pharmaceuticals Private Limited headquartered?

Visa Drugs & Pharmaceuticals Private Limited is headquartered at Room No. A-402/8, Bagree Market 71, Biplabi Rashbehari Basu, Kolkata, West Bengal, 700001.

When was Visa Drugs & Pharmaceuticals Private Limited incorporated?

Visa Drugs & Pharmaceuticals Private Limited was incorporated on 07 July 2008.

Who are the current directors of Visa Drugs & Pharmaceuticals Private Limited?

The current directors of Visa Drugs & Pharmaceuticals Private Limited are

What is the primary industry of Visa Drugs & Pharmaceuticals Private Limited?

The primary industry of Visa Drugs & Pharmaceuticals Private Limited is Manufacturing.

Is Visa Drugs & Pharmaceuticals Private Limited a listed company?

Visa Drugs & Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Visa Drugs & Pharmaceuticals Private Limited?

The authorized capital of Visa Drugs & Pharmaceuticals Private Limited is ₹4.00 Cr, and the paid-up capital is ₹4.00 Cr.

What is the compliance status of Visa Drugs & Pharmaceuticals Private Limited?

The compliance status of Visa Drugs & Pharmaceuticals Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available